Evidence map›Paper›PMID 34075470›Full record

ArticleBioprocess and biosystems engineering2021

A novel strategy of nanosized herbal Plectranthus amboinicus, Phyllanthus niruri and Euphorbia hirta treated TiO

P Maheswari, S Harish, S Ponnusamy, C Muthamizhchelvan

Abstract read
PubMed Publisher
In one paragraph

Article in Bioprocess and biosystems engineering, 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 9 papers.

0numbers the graph read from it
0cells of the map it votes in
9citing papers in PubMed
2.4field-weighted citation impact, top 12% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

9 citing papers in PubMed, 19 citations in OpenAlex.

  1. Review
  2. Article
  3. Review
  4. Review
  5. Review
  6. Review
  7. Review
  8. Review
  9. An insight into the potent medicinal plantThe Nucleus : an international journal of cytology and allied topics · 2022
    Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

4 authors at 2 institutions in 2 countries.

P MaheswariDepartment of Nautical Science, VELS Institute of Science, Technology and Advanced Studies, Thalambur, 603 103, India.
S HarishResearch Institute of Electronics, Shizuoka University, 3-5-1 Johoku, Naka-Ku, Hamamatsu, Shizuoka, 432-8011, Japan. aravindharri@gmail.com.ORCID http://orcid.org/0000-0001-6170-5117
S PonnusamyFunctional Materials and Energy Devices Laboratory, Department of Physics and Nanotechnology, SRM Institute of Science and Technology, Kattankulathur, 603 203, India. suruponnus@gmail.com.
C MuthamizhchelvanFunctional Materials and Energy Devices Laboratory, Department of Physics and Nanotechnology, SRM Institute of Science and Technology, Kattankulathur, 603 203, India.
SRM Institute of Science and Technology · INShizuoka University · JP

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Titanium dioxide nanoparticles exhibit good anticancer and antibacterial activities. They are known to be environmentally friendly, stable, less toxic, and have excellent biocompatibility nature. Due to these properties, they are well suited for biological applications particularly in biomedical applications such as drug delivery and cancer therapy. In this research article, three medicinal herbs namely, Plectranthus amboinicus (Karpooravalli), Phyllanthus niruri (Keezhanelli), and Euphorbia hirta (Amman Pacharisi), were used to modify the surface of the TiO

Indexed as

AgarAnimalsAnti-Bacterial AgentsAntineoplastic AgentsCell LineCell SurvivalEuphorbiaHEK293 CellsHumansHydrogen-Ion ConcentrationMetal NanoparticlesMiceMicrobial Sensitivity TestsModels, ChemicalNanotechnologyPhyllanthusAgarAnti-Bacterial AgentsAntineoplastic AgentsPlant ExtractsPlant PreparationsPowdersTetrazolium SaltsThiazolesthiazolyl blueTitaniumtitanium dioxideHerbal and anticancerKarpooravalliKeezhanelliMedicinal

Identifiers

PMID34075470
OpenAlexW3164729122

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.